| 摘要 |
<p>The invention relates to pharmaceutical compositions for the treatment of pulmonary arterial hypertension one containing a prostacyclin or a prostacyclin analogue, preferably epoprostenol, and the other an endothelin receptor antagonist, preferably bosentan, and to the concomitant use of these compositions to reduce the side effects of the prostcyclin or prostacyclin analogues.</p> |
